Skip to content
Home
About Us
Contributors
Publications
Aron 1 – Renal Cell Carcinoma
Aron 2 – Urothelial carcinoma
Aron 3 – Prostate Cancer
Aron – supplementaries
Contact Us
Menu
Home
About Us
Contributors
Publications
Aron 1 – Renal Cell Carcinoma
Aron 2 – Urothelial carcinoma
Aron 3 – Prostate Cancer
Aron – supplementaries
Contact Us
Publications
All our publications
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study
Alessandro Rizzo
et al. Clin Exp Metastasis
2024
Sex differences in adverse events among cancer patients receiving immune checkpointinhibitors: the MOUSEION-07 systematic review and meta-analysis
Elsa Vitale
Elsa Vitale et al. Sci Rep
2024
The impact of ECOG performance status on efficacy of immunotherapy and immune-basedcombinations in cancer patients: the MOUSEION-06 study
Veronica Mollica
et al. Clin Exp Med
2023
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-basedcombinations: the MOUSEION-05 study
Alessandro Rizzo
et al. Cancer Immunol Immunother
2023
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: TheMOUSEION-04 Study
Alessandro Rizzo
et al. Cancers
2022
Complete remissions following immunotherapy or immuno-oncology combinations incancer patients: the MOUSEION-03 meta-analysis
Matteo Santoni
et al. Cancer Immunol Immunother
2023
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next